Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat

Neurobiol Dis. 2005 Oct;20(1):64-73. doi: 10.1016/j.nbd.2005.02.001.

Abstract

Using a viral vector for mutant (P301L) tau, we studied the effects of gene transfer to the rat substantia nigra in terms of structural and functional properties of dopaminergic neurons. The mutant tau vector caused progressive loss of pars compacta dopaminergic neurons over time, reduced striatal dopamine content, and amphetamine-stimulated rotational behavior consistent with a specific lesion effect. In addition, structural studies demonstrated neurofibrillary tangles and neuritic pathology. Wild-type tau had similar effects on neuronal loss and rotational behavior. In contrast, mutant alpha-synuclein vectors did not induce rotational behavior, although alpha-synuclein filaments formed in nigrostriatal axons. Dopamine neuron function is affected by tau gene transfer and appears to be more susceptible to tau- rather than alpha-synuclein-related damage in this model. Both tau and alpha-synuclein are important for substantia nigra neurodegeneration models in rats, further indicating their potential as therapeutic targets for human diseases involving loss of dopamine neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavior, Animal / physiology
  • Disease Models, Animal
  • Dopamine / metabolism*
  • Gene Transfer Techniques
  • Genetic Vectors / genetics
  • Male
  • Motor Activity / genetics
  • Movement Disorders / genetics
  • Movement Disorders / pathology
  • Movement Disorders / physiopathology
  • Mutation / genetics
  • Nerve Degeneration / genetics*
  • Nerve Degeneration / metabolism
  • Nerve Degeneration / physiopathology
  • Neurofibrillary Tangles / genetics
  • Neurofibrillary Tangles / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Rotation
  • Substantia Nigra / metabolism
  • Substantia Nigra / pathology
  • Substantia Nigra / physiopathology*
  • Tauopathies / genetics*
  • Tauopathies / metabolism
  • Tauopathies / physiopathology
  • alpha-Synuclein / genetics*
  • tau Proteins / genetics*

Substances

  • alpha-Synuclein
  • tau Proteins
  • Dopamine